Neurimmune Holding AG

Switzerland


 
Total IP 65
Total IP Rank # 20,997
IP Activity Score 2.1/5.0    19
IP Activity Rank # 43,989
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

24 9
5 10
9 5
3
 
Last Patent 2025 - Antibody-based therapy of transt...
First Patent 2011 - Human anti-sod1 antibodies
Last Trademark 2022 - NEURIMMUNE
First Trademark 2007 - RTM

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor. ...
2024 Invention Human anti-sod1 antibodies. Provided are novel human copper-zinc superoxide dismutase, also know...
2023 Invention Human-derived anti-dipeptide repeats (dprs) antibody. Provided are novel human-derived dipeptide...
2022 Invention Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage...
Invention Human-derived anti-huntingtin (htt) antibodies and uses thereof. Provided are novel human-derive...
G/S Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, ne...
G/S Pharmaceutical preparations for the treatment of nervous system diseases, infectious diseases, n...
2020 Invention Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof. Provided are novel...
Invention Human-derived anti-huntingtin (htt) antibodies and uses thereof. Provided are novel human-derived...
2019 Invention Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases. Provide...
Invention Human-derived anti-dipeptide repeats (dprs) antibody. Provided are novel human-derived dipeptide ...
Invention Human anti-sod1 antibodies. Provided are novel human copper-zinc superoxide dismutase, also known...
2018 Invention Human islet amyloid polypeptide (hiapp) specific antibodies and uses thereof. Provided are novel ...
G/S pharmaceutical preparations for treating diseases of the nervous system, infectious diseases, neo...
G/S chemical preparations for industrial purposes; chemical preparations for scientific purposes othe...
2016 Invention Novel anti-fibroblast activation protein (fap) antibodies and uses derived thereof. Provided are...
Invention Novel anti-fibroblast activation protein (fap) antibodies and uses derived thereof. Provided are ...
2015 G/S [ Chemicals used in industry; chemical preparations for industrial purposes; chemical preparation...
G/S Chemical products; chemical preparations for industrial purposes; chemical preparations for scie...
G/S Chemicals used in industry, namely chemicals for use in the manufacture of pharmaceutical prepar...
Invention Human derived anti-huntingtin (htt) antibodies and uses thereof. Provided are novel human-derived...
G/S Chemicals used in industry, namely commercial companies producing goods or providing pharmacy, na...
Invention Compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and i...
Invention Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced .beta.-cell dama...
2013 Invention A method of reducing brain amyloid plaques using anti-ab antibodies. This disclosure relates to ...
Invention A method of reducing brain amyloid plaques using anti-a.beta. antibodies. This disclosure relates...
Invention A method of reducing brain amyloid plaques using anti-aß antibodies. This disclosure relates to t...
2012 G/S [ Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases...
G/S [ Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neopl...
2008 G/S Pharmaceutical and veterinary preparations for the treatment of diseases of the nervous system na...
2007 G/S Pharmaceutical and veterinary preparations; diagnostic preparations, included in class 5; dieteti...